What is the main business of Qiagen Polska?

The main business activity of Qiagen Polska focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on December 23, 2014.

Where is the headquarters located?

The headquarters is located at: ul. Powstańców Śląskich 95, 53-332 Wrocław.

What is the share capital?

The share capital of the company is PLN 50,000 (approx. $13,506).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

How much revenue was generated?

In 2024, the company generated total revenue of $10,884,283, representing an increase of 38.6% compared to 2023.

Is the company profitable?

Yes, in 2024 the company was profitable, achieving a net profit of $633,786, meaning the company increased its profit by 197.7%.

What is the largest operating cost?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $7,996,433 in 2024, representing 80% of all operating expenses.

Qiagen Polskasp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2014-12-23

Share capital

50,000.00 PLN

Registered address

ul. Powstańców Śląskich 95, 53-332 Wrocław, Poland

Electronic delivery address

AE:PL-13984-30205-AISJB-25

Financials

Revenue history (in m)

From the notes

Current income tax (CIT due)

$27,421

Filing timeliness

1 of 6 financial statements was filed late (for 2022, 5 days late). All were audited by a statutory auditor.

202515/07/2026
202425/06/2025
202311/07/2024
202220/07/2023
202121/06/2022
202020/05/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Wholesale of pharmaceutical goods230 / 1,141

Top 20%

Division · Wholesale trade2,379 / 19,988

Top 12%

Sector · Wholesale and retail trade; repair of motor vehicles including motorcycles3,313 / 29,903

Top 11%

City · Wrocław560 / 13,706

Top 4.1%

Voivodeship · Dolnośląskie1,256 / 23,907

Top 5.3%

Country · Poland17,276 / 297,932

Top 5.8%

Results vs industry

Revenue

This companyUSD 11.36mMedianUSD 1.07mAverageUSD 22.38m

Net profit

This companyUSD -162.15kMedianUSD 37.89kAverageUSD 879.28k

Operating costs

This companyUSD 11.30mMedianUSD 929.75kAverageUSD 21.06m

Assets

This companyUSD 4.74mMedianUSD 609.81kAverageUSD 11.84m

Industry

Wholesale of pharmaceutical goods (46.46.Z)Primary
Manufacture of medical and dental instruments and supplies (32.5)
Wholesale on a fee or contract basis (46.1)

Public procurement

287 tenders recorded as contractor: 158 national ($6,271,561) and 129 EU ($17,230,004).

Publication date	Subject	Amount	Contracting authority
Oct 23, 2026	Successive supply of reagents for Instytut Medycyny Weterynaryjnej	––	Szkoła Główna Gospodarstwa Wiejskiego w Warszawie
Oct 23, 2026	Supply of reagents (teaching)	$333$333	Uniwersytet Medyczny w Lublinie
Oct 20, 2026	Successive supply of small laboratory equipment, divided into 5 lots, for Zakłady i Kliniki umb	$18,408$18,408	Uniwersytet Medyczny w Białymstoku

Signed on	Subject	Amount	Public buyer
Oct 29, 2026	Laboratory reagents	$201.24	Międzynarodowy Instytut Biologii Molekularnej I Komórkowej w Warszawie
Oct 26, 2026	Reagents and materials for molecular biology experiments	$294.89	Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk
Oct 26, 2026	RNase-Free DNase Set (50);	$355.22	Uniwersytet Warszawski

Date	Subject of dispute	Outcome	Other party
Oct 9, 2025	Appeal	Discontinued	Samodzielny Publiczny Zakład Opieki Zdrowotnej Szpital Uniwersytecki w Krakowie
Jul 28, 2025	Rejection of the application for admission to the procedure	Discontinued	Szpital Uniwersytecki w Krakowie

Authorized Representatives

Małgorzata Izabela Karpińska – President of the Management Board

Katarzyna Spirin Polak – Management Board Member

Manner of representation

The following person is authorised to submit declarations of will on behalf of the company: A) when the management board is a one-person management board – the President of the Management Board or another member of the management board; B) in the case of a multi-member management board – each member of the management board independently.

Ownership

Owner	Shares	Share value	Stake
Qiagen N.v.	1,000	$13,506.21	100%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2015-01-28.

BNP Paribas Bank Polska
59 1750 0009 0000 0000 2789 5263
BNP Paribas Bank Polska
49 1600 1462 1085 0800 6000 0003
BNP Paribas Bank Polska
78 1750 0009 0000 0000 2789 5212

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Competitors

Name	Revenue	Website
NettleS.A.	$85,124,937.06	nettle.pl
Centrum Zaopatrzenia Medycznego Cezal - WrocławS.A.	$25,656,815.87	cezal.com.pl
Curaleaf PolandS.A.	$2,746,800.02	can4med.pl
Gierthsp. z o.o.	$240,006.46	gierth.pl
Zdrowie Ze Znakiem Kangurasp. z o.o.	$177,221.20	zdrowie-kangur.pl
Arjamedicalsp. z o.o.	$29,555.69	arjamedical.com
Intobeautysp. z o.o.	$0.00	intobeauty.pl
Medag Aparatura Medyczna P. Augustynowiczsp. j.	–	medag.pl
Addex Medicalsp. z o.o.	–	addexmedical.com
Esdentsp. z o.o.	–	esdent.pl

Change history

Date	Event
2019-12-16	Address change (Ul. Stępińska 22/30, 00-739, Warszawa → Ul. Powstańców Śląskich 95, 53-332, Wrocław)
2019-12-16	Name change (Q4lab → Qiagen Polska)
2019-02-27	Address change (Ul. Kątna 17, 00-703, Warszawa → Ul. Stępińska 22/30, 00-739, Warszawa)
2018-05-16	Name change (Qialab → Q4lab)
2017-05-30	Name change (Alab-Gen → Qialab)

FAQ

Last updated: 2026-10-07